AAFCPAs Wealth Management, an affiliate company of AAFCPAs, is pleased to announce the addition of Carmen Grinkis, PhD, CLTC, CFP® as a Wealth Advisor and Director of Wealth Management. With over 25 years of diverse experience, Carmen is a seasoned professional providing comprehensive financial planning solutions for individuals, families, business owners, nonprofits & foundations.
She is a licensed investment adviser, a CERTIFIED FINANCIAL PLANNER™ (CFP®), and holds a Certification in Long-Term Care (CLTC). In addition, Carmen has a PhD in Clinical Psychology and fifteen years’ experience as a practicing psychologist. This perspective will benefit our clients because so much of financial planning is life planning. Click here to read Carmen Grinkis’ full profile.>>
“I am excited to join a firm with such a unique offering…and a genuine commitment to excellence,” said Carmen. “I am proud to be a member of this fine organization and multi-disciplinary team, who helps ensure that no stone is left unturned, and all solutions are objectively based on what is best for our clients.”
About AAFCPAs Wealth Management
AAFCPAs Wealth Management is a boutique “fee-based” Registered Investment Advisor (RIA) firm serving individuals & families, retirement plan sponsors, and nonprofits & foundations. As an affiliate of AAFCPAs (Westborough, Boston, Wellesley), AAFCPAs Wealth Management is able to leverage shared knowledge, providing insight into long-range planning, with full consideration for tax implications. AAFCPAs Wealth Management’s solutions are designed for those who appreciate honesty, tax expertise, and personal attention.
AAFCPAs would like to make clients aware of potential credits owed to your organization as a result of a miscalculation of a drug ceiling price. Recently, the drug manufacturer Amgen USA Inc. notified the Health Resources and Services Administration (HRSA) that the 340B ceiling price for multiple products had been calculated incorrectly and that credits may be owed to affected covered entities.
Amgen stated that the ceiling price was improperly calculated from October 2006 through March 2015 on products using NDC labeler codes 55513 and 58406. This includes: Aranesp®, Enbrel®, Epogen®, Neulasta®, Neupogen®, Vectibix®, Nplate®, Prolia®, and Sensipar®. Affected covered entities should receive a credit within the next three to four months based upon activity with the manufacturer, accompanied by a letter detailing the change in price.
AAFCPAs encourages healthcare clients participating in the 340B drug pricing program to click here to review the full listing of affected National Drug Codes (NDCs). >> If you feel that you were overcharged for the purchase of a 340B covered outpatient drug, you may contact Amgen directly at 340BRelations@amgen.com.
AAFCPAs delivers a full range of solutions solving the challenges that AAF’s healthcare clients face, including: guidance on compliance with 340B pharmacy program requirements, and program audits of both on-site and contract pharmacies. If you have any questions or need additional information, please contact your AAF Partner, or Courtney McFarland, CPA: 774.512.4051, cmcfarland@aafcpa.com.
AAFCPAs would like to make you aware that the Massachusetts Department of Revenue (DOR) has recently announced a 2016 Tax Amnesty Program, open to all individuals and businesses who have not filed all Massachusetts tax returns, or have underreported taxes on previously filed returns.
The tax amnesty program is a limited-time opportunity, and allows taxpayers to save on certain penalties, including criminal prosecution. AAFCPAs reminds readers that amnesty programs do not happen every year, and delinquent taxpayers may be subject to greater consequences after MA Tax Amnesty 2016.
The electronic amnesty return will be available from April 1 – May 31, 2016. You may learn more by visiting: mass.gov/TaxAmnesty
AAFCPAs is available to consult on taxpayer eligibility based on the scope of the program, your tax type, and the periods covered. We are also available for tax planning and compliance solutions, including: completion of your amnesty returns and schedules, and calculation of your total amnesty balance due.
If you have any questions about MA Tax Amnesty 2016, or year-end or multi-year tax planning, please contact your AAFCPA partner.
Net Assets Magazine | John Buckley, CPA, Partner, advises national, NBOA-member private schools to evaluate the intrinsic risks embedded in the potential rewards of technologies.
From online tuition systems to point-of-sale credit card readers, established and emerging financial technologies foster greater efficiency for independent schools, along with superior convenience for vendors, parents, students and supporters. At the same time, they open up easier and faster ways to commit fraud and can offer false reassurance when it comes to safeguarding a school’s financial assets, ultimately undermining diligence and vigilance.
The true impact of fraud can be disastrous and far-reaching, including financial loss, diminished productivity, legal problems and tarnished reputations. Independent schools’ communities of lenders, donors, board members and parents expect high ethical behavior and effective internal controls. In fact, technology often presents an enormous dilemma, in that efficiency and effectiveness can be competing imperatives affecting internal controls.
Schools large and small must evaluate the intrinsic risks embedded in the potential rewards of technologies. Every school must find the right balance between its tolerance for risk and its ability to allocate sufficient resources to achieve internal controls.
Here’s a look at a few common technologies, their potential for fraud and the kinds of controls and practices that can mitigate or neutralize these risks (some of which your bank may already require).
Download the PDF:
Reprinted with permission. This article appeared in the March/April 2016 issue of Net Assets Magazine, a publication of the National Business Officers Association (NBOA).
AAFCPAs Partner and Chief Marketing Officer Matthew Boyle has been selected by Merrimack College to serve on a panel on February 29th titled: Reaching the C-Suite: Corporate executives talk about their journey from Merrimack to the Chief Officer’s role.
Matthew will join Dennis Leonard, President of Delta Dental of Massachusetts, and Kevin Rhodes, Executive Vice President and Chief Financial Officer of Brightcove Inc. to discuss their journey from Merrimack to the “C-Suite” in this one-hour panel discussion, moderated by Girard School of Business Dean Mark Cordano. Matthew, Dennis and Kevin will talk about their career paths, share information about the keys to their success, and offer advice for students and fellow alumni on how to stand out and be successful in the workplace.
“I am truly proud to be an alumnus of Merrimack College,” said Matthew. “Merrimack built the foundation for my professional career, and inspired me to pursue ambitious goals, place ethics at the core of my decision making, and seek innovation in order to add maximum value to customers.”
Merrimack Alumni and their guests are invited to attend.
Matthew Boyle brings strategic business insight to the AAFCPAs Partner team. He is recognized as an authority in the field of accounting marketing, and his expertise and cutting-edge thinking has been recognized nationally by industry leaders and business executives alike. Matthew has over 13 years of experience in leading high-energy teams, and transforming organizations to grow by institutionalizing disciplines that lead to excellent client service. Click here to read Matthew’s full profile.>>
The Financial Accounting Standards Board (FASB) continued its Phase 1 deliberations at its March 2nd, 2016 Board Meeting on the proposed FASB Accounting Standards Update (ASU), Not-for-Profit Entities (Topic 958) and Health Care Entities (Topic 954): Presentation of Financial Statements of Not-for-Profit Entities.
Significant Decisions Made at the Board’s March 2016 Meeting:
The proposed ASU would affect substantially all nonprofits as well as creditors, donors, grantors, and others that use their financial statements. AAFCPAs would like to make clients aware of the significant FASB decisions made on March 2:
- Nonprofits will be required to report internal transfers that are a result of board designations, appropriations and similar actions, either on the face of the financial statements or in the notes. Examples will be provided to illustrate different ways to report such information.
- Nonprofits will be required to provide quantitative and qualitative information about financial assets available at the balance sheet date to meet cash flow needs for general expenditures within one year of the balance sheet date. Examples will be provided in the final ASU to illustrate different ways to report such liquidity information.
As a reminder, all of the reported decisions are tentative and may be changed at future Board meetings. It is expected that Phase 1 of the proposed update will be completed and the final ASU, including effective dates, will be issued by mid-June 2016.
AAFCPAs will continue to follow the Board’s deliberations closely. As always, we will keep you informed and provide further updates as they become available.
If you have any additional questions about how the new ASU will impact you, please contact your AAFCPA partner, or Matt Hutt, Partner, CPA, CGMA at 774.512.4043, mhutt@aafcpa.com.
Previous FASB Decisions:
- FASB’s Technical Agenda for NFP Financial Statements Project Organized in Two Phases
- AAFCPAs’ Update on Decisions Reached at the FASB’s December 2015 Meeting
- AAFCPAs’ Update on Decisions Reached at the FASB’s February 2016 Meeting
AAFCPAs would like to make clients aware that, as of March 11, 2016, the new Federally Qualified Health Centers (FQHCs) Cost Report Form 224-14 had not been finalized and is reportedly still in review by the Federal Office of Management and Budget (OMB). It is reported that the Centers for Medicare & Medicaid Services (CMS) anticipate the release of final forms and instructions in the spring of 2016.
Freestanding FQHCs with cost reporting periods beginning on or after October 1, 2014, are required to use the proposed (and more detailed) Form 224-14. This form supersedes the previously required FQHC Form 222-92. You may preview the draft form CMS-224-14 by clicking here.>>
The annual Cost Report filing is traditionally due five months after fiscal year end; however, it is expected that the CMS will provide extensions to complete the reports due to the delay in issuing a final form. For health centers with a fiscal year end of September 30, 2015, the reports were technically due on February 29, 2016. An automatic extension period applies as the form has not yet been finalized.
AAFCPAs will continue to keep clients updated with any information regarding the finalization of the report and extended due dates. AAF will be available for assistance in preparation and filing of the new form, and to provide guidance and best practices in implementing the changes.
If you have any additional questions about preparation or filing of your FQHC Medicare Cost Report, please contact your AAFCPA partner, or Matt Hutt, Partner, CPA, CGMA at 774.512.4043, mhutt@aafcpa.com.
Many entities compensate their employees, not by “cash salary,” but rather by using equity awards, commonly in the form of what is referred to as “stock compensation.” The amendments in Accounting Standards Update 2014-12 – Compensation – Stock Compensation (Topic 718), apply to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period.
Entities commonly issue share-based payment awards to employees requiring a specific performance target be achieved in order for the employee to become eligible to vest in the awards. Examples of typical performance targets include: an entity attaining a specified profitability metric, or the entity selling shares in an initial public offering (IPO). Generally, awards with performance targets also require the employee to render services until the performance target is achieved. In some cases, however, the terms of an award may provide that the performance target could be achieved AFTER the employee completes the requisite service period. The requisite service period is the period during which an employee is required to provide service in exchange for an award. Current U.S. generally accepted accounting principles (U.S. GAAP) does not contain explicit guidance on how to account for those types of share-based payments.
The amendments in ASU 2014-12 require that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved, and should represent the compensation cost attributable to the period (or periods) for which the requisite service already has been rendered. If the performance target becomes probable of being achieved before the end of the requisite service period, the remaining unrecognized compensation cost for which requisite service has not yet been rendered should be recognized prospectively over the remaining requisite service period.
The total amount of compensation cost recognized during and after the requisite service period should reflect the number of awards that are expected to vest, and should be adjusted to reflect those awards that ultimately vest. The requisite service period ends when the employee can cease rendering service and still be eligible to vest in the award if the performance target is achieved. The stated vesting period [which includes the period in which the performance target could be achieved] may differ from the requisite service period.
ASU 2014-12 does not change existing U.S. GAAP that requires the performance condition to be substantive in order to be relevant to the accounting treatment. Also, a substantive performance condition that is uncertain, such as an IPO, may result in no compensation cost being recognized during the requisite service period.
AAFCPAs recommends that companies evaluate adding liquidity events as performance conditions to share-based payment arrangements as a result of this clarification.
What are the Effective Dates?
The amendments in ASU 2014-12 are effective for annual periods beginning after December 15, 2015. Earlier adoption is permitted.
Entities may apply the amendments in ASU 2014-12 either:
- Prospectively to all awards granted or modified after the effective date; or
- Retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements, and to all new or modified awards thereafter.
If you have any questions about accounting for shared-based payments, please contact your AAFCPA partner, or Jeffrey Mead, CPA, CGMA, Partner at 774.512.4143, jmead@aafcpa.com.
David Consigli, Jr., CPA, ABV, AAFCPAs’
Director of Business Valuations, will volunteer his time and expertise to present “Everything You Need to Know About Business Valuations” as part of the Salem Bar Association’s monthly Smart Talks Series. David will offer guidance for attorneys on when business valuations may be beneficial in litigation, and provide real examples of cases involving different valuation scenarios. Dave has been called upon as a litigation expert witness, appearing in the Massachusetts Middlesex County District Court, Massachusetts Norfolk County Superior Court, Massachusetts Suffolk Probate and Family Court, and the United States Federal Court.
“David is very knowledgeable in the field of business valuation and presents his findings in a concise manner, which clients, attorneys and judges can easily understand,” says attorney Jean Porcello.“This presentation will assist the legal
profession in any valuation questions they may have.”
When
Wednesday, March 16, 2016
1:00 – 2:00 pm
Where
Essex County Bar Advocate Office
221 Essex Street, 3rd Floor,
Salem, MA